Great Novel Therapeutics Biotech & Medicals (TPEX:7427)
Taiwan flag Taiwan · Delayed Price · Currency is TWD
39.65
-0.15 (-0.38%)
May 2, 2025, 2:00 PM CST

TPEX:7427 Ratios and Metrics

Millions TWD. Fiscal year is Jan - Dec.
Fiscal Year
CurrentFY 2024 FY 2023 FY 2022 FY 2021 FY 2020 2016 - 2019
Period Ending
May '25 Dec '24 Dec '23 Dec '22 Dec '21 Dec '20 2016 - 2019
Market Capitalization
1,7441,4842,5621,823936-
Upgrade
Market Cap Growth
-42.09%-42.09%40.55%94.83%--
Upgrade
Enterprise Value
1,1718842,0631,731777-
Upgrade
Last Close Price
39.9534.0064.1954.8435.14-
Upgrade
PS Ratio
1034.76880.65528.303376.081485.29-
Upgrade
PB Ratio
2.752.344.796.594.49-
Upgrade
P/TBV Ratio
2.882.455.076.987.81-
Upgrade
EV/Sales Ratio
-524.33425.313205.061233.73-
Upgrade
Debt / Equity Ratio
0.020.020.03---
Upgrade
Asset Turnover
0.000.000.010.000.00-
Upgrade
Inventory Turnover
0.150.15----
Upgrade
Quick Ratio
26.7726.7729.9520.565.7912.64
Upgrade
Current Ratio
27.4327.4330.4720.875.8012.67
Upgrade
Return on Equity (ROE)
-17.97%-17.97%-15.04%-27.68%-21.80%-33.34%
Upgrade
Return on Assets (ROA)
-11.51%-11.51%-9.68%-16.58%-12.83%-17.66%
Upgrade
Return on Capital (ROIC)
-11.81%-11.81%-9.98%-17.73%-13.88%-19.92%
Upgrade
Earnings Yield
-6.02%-7.07%-2.38%-3.68%-3.83%-
Upgrade
FCF Yield
-4.53%-5.32%-2.26%-4.23%-3.63%-
Upgrade
Buyback Yield / Dilution
-13.60%-13.60%-50.23%-14.54%-33.09%-16.83%
Upgrade
Source: S&P Global Market Intelligence. Standard template. Financial Sources.